Most healthcare teams treat HIPAA compliance as a tax. It is a cost of doing business, a drag on shipping, a box to check before launch. A smaller group treats it as a moat, and those teams tend to pull ahead. The gap between them is less about budget than about what they think compliance is for.

This is not a semantic distinction. How you frame compliance decides whether you invest in it early, when it is cheap and compounding, or scramble for it late, when it is expensive and everyone can see the seams.

Why compliance feels like a tax

The tax framing is understandable. Compliance work rarely ships a feature a customer asked for. It shows up as extra steps, extra reviews, and extra cost, with the payoff being an absence of trouble that is hard to point to in a demo.

So teams do the minimum required, as late as they can get away with, and treat every control as a line item to trim. That mindset is exactly what turns compliance into a drag, because the cheapest, latest version of it is also the most painful to bolt on.

Why it is really a moat

Compliance looks different once you see what the bar actually keeps out.

Clearing it is hard on purpose. Signing business associate agreements (BAAs), encrypting protected health information (PHI) everywhere it moves, passing audits, and earning a certification like HITRUST take real investment. Plenty of vendors will not or cannot make it. That difficulty is the moat: the same bar that costs you something to clear is the bar a competitor has to clear too, and many will not.

It also wins trust, which in healthcare is what wins deals. Buyers vet vendors on exactly this. "We sign a BAA" and "we are HITRUST certified" move a sale forward in a way that a longer feature list does not, because the buyer is asking a yes-or-no question about whether they can legally and safely hand you patient data. The stakes behind that question are public: every substantial healthcare breach is posted on the HHS breach portal, and no buyer wants to land there because of a vendor they chose.

And it compounds. A team that builds encryption, access control, and a BAA-ready posture in from the start moves faster on every later decision, because the foundation is already there. The team that deferred all of it pays the full bill at once, usually under deadline pressure, and often after an incident has made the cost concrete.

AI makes the moat wider

The AI era sharpens the advantage. The frontier models and tools most builders reach for are not compliant on their own, and most consumer AI cannot legally touch PHI at all.

That means a healthcare product that can safely use AI on patient data, because it built the compliant foundation to do so, has something most of its competitors cannot quickly copy. The compliance work that looked like a tax becomes the reason you can ship an AI feature a rival cannot. The gap between organizations that can see and govern their AI use and those that cannot is already wide: in Paubox's 2025 research, 85% of healthcare IT leaders suspected staff were using unauthorized AI tools, and only 26% had visibility into it.

The tax mindset is the expensive one

Here is the trap in treating compliance as a tax: the belief is self-fulfilling. Minimize the investment and you get the slow, retrofitted version, which confirms that compliance is a burden. Invest in it as an advantage and it starts paying back, in deals closed, in AI features you can actually ship, and in the incidents that never happen.

The spend is similar either way. What changes is the return, and the return depends on whether you built compliance in early or bolted it on late.

Start here

If you are deciding how much to invest in compliance, the real question is how much of a lead you want to build. In a market where most competitors treat HIPAA as a cost to minimize, building the opposite way is a durable advantage.

For the practical side of building on that foundation, especially with AI, see our guide to building with AI in healthcare, or start with HIPAA compliant email: the definitive guide.